1995Clinical Nuclear MedicineRequires access

Tc-99m Sestamibi Uptake by Parathyroid Carcinoma

Dwight M. Achong, Elizabeth Oates

Open publisher page 4 citations

Abstract

Tc-99m sestamibi (MIBI) is increasingly used for the preoperative localization of parathyroid adenoma. As experience is gained with this radiopharmaceutical, instances of uptake by non-adenomas will be encountered. A case of focal Tc-99m MIBI uptake by parathyroid carcinoma mimicking parathyroid adenoma is presented.

About this research paper

What this paper is about

Tc-99m sestamibi (MIBI) is increasingly used for the preoperative localization of parathyroid adenoma. As experience is gained with this radiopharmaceutical, instances of uptake by non-adenomas will be encountered. A case of focal Tc-99m MIBI uptake by parathyroid carcinoma mimicking parathyroid adenoma is presented.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Tc-99m sestamibi (MIBI) is increasingly used for the preoperative localization of parathyroid adenoma. As experience is gained with this radiopharmaceutical, instances of uptake by non-adenomas will be encountered. A case of focal Tc-99m MIBI uptake by parathyroid carcinoma mimicking parathyroid adenoma is presented.

Key concepts: Medicine, Parathyroid carcinoma, Parathyroid adenoma, Technetium Tc 99m Sestamibi, Parathyroid neoplasm, Adenoma, Carcinoma, Radiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Tc-99m Sestamibi Uptake by Parathyroid Carcinoma — Research Paper | ScholarLens